Current Organic Synthesis
Title:Meet Our Editorial Board Member
Volume: 17 Issue: 4
Author(s): David G. Lynn
Affiliation:
Export Options
About this article
Cite this article as:
Lynn G. David, Meet Our Editorial Board Member, Current Organic Synthesis 2020; 17 (4) . https://dx.doi.org/10.2174/157017941704200727153906
DOI https://dx.doi.org/10.2174/157017941704200727153906 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |
4
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Improvement of the Mechanical and Thermal Properties of Bayfol CR6-2 Polymer using UV Radiation
Recent Patents on Mechanical Engineering REM Sleep Loss and Recovery Regulates Blood-Brain Barrier Function
Current Neurovascular Research Antidepressant Potential of Peptides: New Insights as Future Therapeutic
CNS & Neurological Disorders - Drug Targets Cytochrome P450 Regulation and Drug Biotransformation During Inflammation and Infection
Current Drug Metabolism The Role of Glyoxalase in Glycation and Carbonyl Stress Induced Metabolic Disorders
Current Protein & Peptide Science TLR7/9 Antagonists as Therapeutics for Immune-Mediated Inflammatory Disorders
Inflammation & Allergy - Drug Targets (Discontinued) Gene Delivery by Functional Inorganic Nanocarriers
Recent Patents on DNA & Gene Sequences The Role of STATs in Inflammation and Inflammatory Diseases
Current Pharmaceutical Design The Human Obesity Epidemic - A Physiological Perspective
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents The Discovery of CDP323, a Potent Alpha4 Integrin Antagonist
Current Immunology Reviews (Discontinued) Multitarget Cannabinoids as Novel Strategy for Alzheimer Disease
Current Alzheimer Research Targeting of Leukemia-Initiating Cells to Develop Curative Drug Therapies: Straightforward but Nontrivial Concept
Current Cancer Drug Targets Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders
Current Drug Safety Gene-Activation Mechanisms in the Regression of Atherosclerosis, Elimination of Diabetes Type 2, and Prevention of Dementia
Current Molecular Medicine N-Terminal Microdomain Peptide from Human Dihydroorotate Dehydrogenase: Structure and Model Membrane Interactions
Protein & Peptide Letters Hypertension to Heart Failure: New Developmental Strategies do not Cross a Clinical and Therapeutic Divide
Current Pharmaceutical Design Effect of Withania somnifera Supplementation on Rotenone-Induced Oxidative Damage in Cerebellum and Striatum of the Male Mice Brain
Central Nervous System Agents in Medicinal Chemistry Review of Interventions for Parental Depression from Toddlerhood to Adolescence
Current Psychiatry Reviews Induction of Apoptosis in Macrophages via Kv1.3 and Kv1.5 Potassium Channels
Current Medicinal Chemistry Acceptability of Nose-to-Brain Drug Targeting in Context to Its Advances and Challenges
Drug Delivery Letters